Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005

Forensic Science International

Volumn 161, Issue 2-3, 2006, Pages 202-208

  Teng, Shu Fang ^a   Wu, Shou Chien ^a   Liu, Chiareiy ^a   Li, Jih Heng ^a   Chien, Chun Sheng ^a  

^a Executive Yuan   (Taiwan)

Author keywords

Amphetamine; GC MS; MDA; MDEA; MDMA; Methamphetamine

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; CAFFEINE; CHLORZOXAZONE; DIAZEPAM; EPHEDRINE; KETAMINE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; NICOTINAMIDE;

ARTICLE; DRUG SCREENING; DRUG TRAFFIC; GAS CHROMATOGRAPHY; MASS SPECTROMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARD; TABLET; TAIWAN;

EID: 33746478158     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2006.03.035     Document Type: Article

References (21)

1. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. Can. Med. Assoc. J. 165 (2001) 917-928
2. Ministry of Justice, Statistics Abstract, March 2005.
3. Department of Health, Drug of Abuse Case and Testing Statistics, April 2005.
4. Chuang S.-F., Wu S.-C., Tsay W.-I., Li J.-H., Liu R.H., Liu J.-T., Lee T.-C., Yang Y.-T., and Sun M.-P. Analysis of MDMA and ketamine samples seizures in Taiwan. Taiwan J. Public Health 24 (2005) 264-273
5. Makino Y., Tanaka S., Kurobane S., Nakauchi M., Terasaki T., and Ohta S.J. Profiling of illegal amphetamine-type stimulant tablets in Japan. Health Sci. 49 (2003) 129-137
6. Cheng W.-C. Chemical profiling of 3,4-methylenedioxymethamphetamine. Forensic Sci. 48 (2003) 1249-1259
7. Zhao H., Brenneisen R., McNally A.J., Elsohly M.A., Murphy T.P., and Salamone S.J. Profiles of urine samples taken from ecstasy users at rave parties: analysis by immunoassays, HPLC, and GC-MS. J. Anal. Toxicol. 25 (2001) 258-269
8. Armbruster D.A., Tillman M.D., and Hubbs L.M. Limit of detection (LOD)/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin. Chem. 40 (1994) 1233-1236
9. The General Situation of Administrative Measures Against Narcotics and Stimulants Abuse, Compliance and Narcotics Division (Ed.), Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare, Japan, The General Situation of Administrative Measures Against Narcotics and Stimulants Abuse, 2003.
10. Katagi M., Tsutsumi H., Miki A., Nakajima K., and Tsuchihashi H. Analyses of clandestine table of amphetamine and their designer drugs encountered in recent Japan. Jpn. J. Forensic Toxicol. 20 (2002) 303-319
11. Makino Y. The current situation and future issue of forensic examination of tablet form drug (ecstasy). J. Police Sci. 57 (2004) 111-122
12. Dal Cason T.A. An evaluation of potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homolog. Forensic Sci. 35 (1990) 675-697
13. Fineschi V., and Masti A. Fatal poisoning by MDMA (ecstasy) and MDEA. Int. J. Legal Med. 108 (1996) 272-275
14. Ahmad K. Increased use of amphetamine-type stimulants threatens East Asian countries. Lancet 359 (2002) 1927
15. Makino Y., Urano Y., and Nagano T. Impurity profiling of ephedrines in methamphetamine by high-performance liquid chromatography. Chromatography A 947 (2002) 151-154
16. Wolff K., Hay A.W.H., Sherlock K., and Conner M. Contents of "ecstasy". Lancet 346 (1995) 1100
17. Jansen K., Psych M., and Darracot-Cankovic R. The nonmedical use of ketamine. Psychoactive Drugs 33 (2001) 151-158
18. Europol, The Hague, The Netherlands, XTC Catalogue File No. 2521-15r3, 2002.
19. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man. fifth ed. (2000), Chemical Toxicology Institute, Foster City, California 49-51
20. In: Moffat A.C. (Ed). Clarke's Isolation and Identification of Drugs. second ed. (1986), The Pharmaceutical Press, London 763-764
21. Substance Abuse (2003), National Bureau of Controlled Drugs, Taiwan, Substance Abuse pp. 273-284